ARTICLE
4 January 2019

Brokerage Firm Settles Charges For Selling IPOs To Restricted Persons

CW
Cadwalader, Wickersham & Taft LLP

Contributor

Cadwalader, established in 1792, serves a diverse client base, including many of the world's leading financial institutions, funds and corporations. With offices in the United States and Europe, Cadwalader offers legal representation in antitrust, banking, corporate finance, corporate governance, executive compensation, financial restructuring, intellectual property, litigation, mergers and acquisitions, private equity, private wealth, real estate, regulation, securitization, structured finance, tax and white collar defense.
A global investment banking and brokerage firm agreed to settle FINRA charges of selling IPO shares to "restricted persons."
United States Finance and Banking

A global investment banking and brokerage firm agreed to settle FINRA charges of selling IPO shares to "restricted persons."

According to the Letter of Acceptance, Waiver, and Consent, the firm violated FINRA Rule 5130 by making over 1,400 prohibited sales of IPO shares in 325 offerings to 149 customer accounts where restricted persons had a "beneficial interest." FINRA stated that the firm allowed the "associated persons of broker-dealers and/or immediate family members of . . . financial advisors" ("FAs"), restricted persons normally prohibited from buying IPO shares, to receive shares due to failures in the firm's eligibility tracking system. FINRA alleged that at least 120 different FAs carried out the prohibited IPO sales.

FINRA claimed that these transactions took place because the firm failed to design adequate supervisory systems to achieve compliance with FINRA Rule 5130, failed to provide sufficient training to its employees regarding compliance, and failed to enforce existing written procedures. Additionally, FINRA stated that the firm failed to respond sufficiently upon discovering red flags.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More